A federated data platform AI discharge tool hailed as “potentially transformational” by Wes Streeting is at the centre of a spiralling regulatory row, HSJ can reveal.
The main concerns centre around whether the tool had been classified as a medical device by the Medicines and Healthcare Products Regulatory Agency, given that it was generating patient discharge summaries that, if incorrect, could impact continuity of care.
There have also been concerns about the information governance implications of using patient data to develop and validate the tool and whether this was being considered as direct care.
Read full story (paywalled)
Source: HSJ, 15 December 2025
0
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now